JENA LALLEY: Open Payments
NPI 1083241129 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 20 payments from 15 companies in 2025. Trend: 2023 $536 · 2024 $609 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 2 | $51 |
| Grifols USA, LLC | 2 | $46 |
| Acella Pharmaceuticals, LLC | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $36 |
| Lundbeck LLC | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: INSPIRE, Gamunex-C, NP Thyroid 60, TREMFYA, VYEPTI, ZERBAXA, INJECTAFER, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
